CHONDROSPHERE (Spherox®)
Clinical Indication
Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the knee in adults
Local guidance
Implementation date 7th June 2018
Date of classification
May 2018
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.